NASDAQ:EXAC

Exactech (EXAC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$49.25
$49.30
50-Day Range
N/A
52-Week Range
$23.75
$50.95
Volume
255,640 shs
Average Volume
182,742 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EXAC stock logo

About Exactech Stock (NASDAQ:EXAC)

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

EXAC Stock News Headlines

Putin and other countries have a plan
Did you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon.
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Ranking SEC men's basketball coaches by win total
Chaney Johnson: A year in review
See More Headlines
Receive EXAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/30/2017
Today
4/23/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:EXAC
CUSIP
30064E10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • R. William Petty M.D. (Age 74)
    Executive Chairman of the Board
  • David W. Petty (Age 50)
    Chief Executive Officer, President and Director
  • Joel C. Phillips CPA (Age 49)
    Chief Financial Officer, Executive Vice President, Treasurer
  • Bruce E. Thompson (Age 59)
    Senior Vice President , General manager- Biologics and Spine Division
  • Gary J. Miller Ph.D. (Age 69)
    Executive Vice President - Research and Development
  • Donna M. Edwards (Age 44)
    Vice President, Legal and General Counsel
  • Betty A. Petty (Age 74)
    Vice President - Administration, Corporate Secretary
  • James G. Binch (Age 69)
    Independent Director
  • W. Andrew Krusen Jr. (Age 68)
    Independent Director
  • William B. Locander Ph.D. (Age 73)
    Independent Director

EXAC Stock Analysis - Frequently Asked Questions

How were Exactech's earnings last quarter?

Exactech Inc (NASDAQ:EXAC) announced its quarterly earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.03. The medical equipment provider had revenue of $61.40 million for the quarter, compared to analysts' expectations of $61.78 million.

What other stocks do shareholders of Exactech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exactech investors own include Immersion (IMMR), Verizon Communications (VZ), Allergan (AGN), Conformis (CFMS), Johnson & Johnson (JNJ), Zimmer Biomet (ZBH), Achieve Life Sciences (ACHV), Amgen (AMGN), Broadcom (AVGO) and Bausch Health Companies (BHC).

This page (NASDAQ:EXAC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners